Timber Hill’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,600
Closed -$256K 361
2017
Q4
$256K Sell
2,600
-10,600
-80% -$1M 0.02% 528
2017
Q3
$1.24M Sell
13,200
-15,800
-54% -$1.68M 0.12% 159
2017
Q2
$3.22M Buy
29,000
+2,200
+8% +$233K 0.12% 135
2017
Q1
$2.63M Buy
26,800
+700
+3% +$66.7K 0.02% 586
2016
Q4
$2.4M Buy
26,100
+8,400
+47% +$724K 0.01% 816
2016
Q3
$1.5M Buy
17,700
+4,600
+35% +$386K 0.01% 926
2016
Q2
$1.07M Buy
13,100
+2,400
+22% +$183K 0.01% 1209
2016
Q1
$765K Sell
10,700
-16,200
-60% -$1.09M ﹤0.01% 1387
2015
Q4
$1.91M Buy
26,900
+6,400
+31% +$430K 0.01% 1018
2015
Q3
$1.26M Buy
20,500
+14,000
+215% +$979K 0.01% 1283
2015
Q2
$471K Sell
6,500
-10,800
-62% -$797K ﹤0.01% 1941
2015
Q1
$1.33M Buy
17,300
+8,300
+92% +$594K 0.01% 1265
2014
Q4
$604K Sell
9,000
-15,000
-63% -$947K ﹤0.01% 1760
2014
Q3
$1.46M Sell
24,000
-17,900
-43% -$1.1M 0.01% 1334
2014
Q2
$2.46M Sell
41,900
-1,600
-4% -$93.7K 0.01% 1031
2014
Q1
$2.52M Sell
43,500
-200
-0.5% -$10.7K 0.01% 1019
2013
Q4
$2.34M Sell
43,700
-7,100
-14% -$421K 0.01% 1267
2013
Q3
$3.14M Sell
50,800
-6,900
-12% -$413K 0.01% 1143
2013
Q2
$3.5M Buy
+57,700
New +$3.44M 0.01% 1035

Other funds holding DGX

Timber Hill's DGX Position: Q2 2017 in Review

Timber Hill sold out of Quest Diagnostics (DGX) in Q2 2017, closing a stake of 5,855 shares — an estimated $619K sold.

Timber Hill first reported a position in DGX in Q4 2013 and held it in 8 quarters. The position peaked at $1.98M in Q1 2014. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

  • Timber Hill reported no remaining Quest Diagnostics position as of Q2 2017 after selling out during the quarter.
  • Timber Hill sold 5,855 Quest Diagnostics shares in Q2 2017, an estimated $619K.
  • Timber Hill first reported a position in Quest Diagnostics in Q4 2013 and held it in 8 quarters.
  • Timber Hill's Quest Diagnostics position peaked at $1.98M in Q1 2014.
  • 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.